White House Trade Adviser Navarro Blasts ‘Swamp Creatures’ And ‘Big Pharma’ For Ignoring Trump’s ‘Buy American’ Order To Reestablish U.S. Medical Supply Chain

Maybe these CEOs should be explaining to a judge why they are ignoring the president’s directive

By: Jon Dougherty @JonDougherty10

(TNS) We’re all about capitalism and free markets, but when the president of the United States issues an order aimed at helping to reestablish a domestic medical equipment supply chain during a pandemic, we expect it to be followed.

And yet, too many “Swamp creatures” and Big Pharma executives seem to think they are exempt.

As Spectator USA reported Thursday, several firms are ignoring President Donald Trump’s “Buy American” executive order calling for a stronger medical supply chain after discovering too late that our country has become far too dependent on Communist China for personal protective equipment and drugs.

take our poll - story continues below

Will You Be Voting In Person November 3rd?

  • Will You Be Voting In Person November 3rd?  

  • This field is for validation purposes and should be left unchanged.
Completing this poll grants you access to Breaking First updates free of charge. You may opt out at anytime. You also agree to this site's Privacy Policy and Terms of Use.

 

Specifically, “Navarro is hitting back at a group of Big Pharma lobbyists, medical organizations, and free trade groups” for ignoring the president’s order:

Navarro, the assistant to the president for trade and manufacturing, told The Spectator that Big Pharma’s opposition to the executive order, which would require government agencies to purchase pharmaceutical products made in the US, because it wants to ‘preserve its offshore oligopoly’.

“All the EO would do is ensure that government agencies, including the VA, HHS, and DoD, Buy American,” Navarro said. “America is more than up to that task and Big Pharma and its well-heeled Swamp Creatures need to stop being such a divisive element in American politics.”

 

His comments come in response to a letter drafted by the Association for Accessible Medicines and signed by over 40 organizations, including PhRMA, the drug industry’s main lobby, alleging that the order will “destabilized the supply chain…as we fight a global pandemic.”



“At this time, while supply chains for a broad range of US industries are stressed due to the global COVID-19 crisis and a number of factors related to the crisis already raised concerns about shortages, it is important that we do not take any measures that could undermine the complex arrangements between firms that allow for efficient delivery of medicines to patients,” the draft letter states.

 

That’s bogus, Navarro noted, because the president’s EO contains exemptions.

“None of the Buy American provisions in the proposed Executive Order would apply during the current COVID-19 crisis,” he explained. “That’s a Big Pharma red herring designed to preserve its offshore oligopoly at the expense of American citizens.

 



“If this crisis teaches us anything at all, it is that we cannot rely on Big Pharma, which is renown already for its price gouging, to provide America during the China virus crisis with the medicines and medical supplies we urgently need from its offshored production,” the trade rep continued.

“Even if Big Pharma’s offshore operations want to send America what we urgently need, the foreign governments of the countries where their supply chains and plants are located are already forbidding the export of critically needed items,” he said.

 

“Ten of the top 20 countries exporting medicines to the US, including four of the top five, have already imposed some form of restrictions.”

Trump has made it a priority to find ways to lower costs of prescription drugs for Americans, and he seems especially keen to ensure that Americans aren’t left wanting during national emergencies because we can’t get supplies from the world’s biggest petri dish and competitor, China.




 

Spectator noted further:

A report from the Associated Press traced major supply shortages of personal protective equipment (PPE) back to China. The Chinese government initially shut down pharmaceutical manufacturers after the coronavirus outbreak, and when those plants reopened, China strictly limited exports to save supplies for its own medical providers.

China has since attempted to fight back against these reports, claiming to ‘donate’ PPE and other supplies to European countries dealing with coronavirus, including Italy and the Czech Republic. In reality, the Czech Republic paid nearly $550,000 for 100,000 rapid COVID-19 tests, 80 percent of which were determined to be faulty.

 

There will always be time for profit. But right now, during this pandemic and national emergency, the president’s orders must be followed or some med company CEOs should to be explaining to judges and juries (and the American people) why they refused.

 

This article originally appeared at The National Sentinel and was republished with permission.

FOLLOW US on Twitter @Breaking_1st for News On Time.

Scroll down to leave a comment!

Please take a moment and consider sharing this article with your family and friends. Thank you, we appreciate it!

You Might Like
Input your search keywords and press Enter.